Lobbying disclosures · Lobbying report
LLY: third_quarter 2026 lobbying report
Issues related to healthcare Issues related to trade
Follow LLY- Became public
- Oct 16, 2026, 1:01 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 4:17 AM EST
Why this is connected
Legal-name match: ELI LILLY AND COMPANY is ELI LILLY & Co (https://www.sec.gov/Archives/edgar/data/59478/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/aa2a8327-bb1e-4815-a3fb-c713e60d2423/","filing_uuid":"aa2a8327-bb1e-4815-a3fb-c713e60d2423","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/aa2a8327-bb1e-4815-a3fb-c713e60d2423/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Garrett Ventry","dt_posted":"2026-10-16T13:01:25-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"324 Royal Palm Way","registrant_address_2":"Suite 226B","registrant_different_address":true,"registrant_city":"Palm Beach","registrant_state":"FL","registrant_zip":"33408","registrant":{"id":401106573,"url":"https://lda.gov/api/v1/registrants/401106573/","house_registrant_id":45588,"name":"GRV STRATEGIES LLC","description":null,"address_1":"324 Royal Palm Way","address_2":"Suite 226B","address_3":null,"address_4":null,"city":"Palm Beach","state":"FL","state_display":"Florida","zip":"33408","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GARRETT VENTRY","contact_telephone":"+1 716-628-4593","dt_updated":"2026-07-16T10:34:07.459974-04:00"},"client":{"id":63502,"url":"https://lda.gov/api/v1/clients/63502/","client_id":63502,"name":"ELI LILLY AND COMPANY","general_description":"Biopharmaceutical company","client_government_entity":null,"client_self_select":false,"state":"IN","state_display":"Indiana","country":"US","country_display":"United States of America","ppb_state":"IN","ppb_state_display":"Indiana","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to healthcare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138159,"prefix":"mr","prefix_display":"MR.","first_name":"GARRETT","nickname":null,"middle_name":null,"last_name":"VENTRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to trade","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138159,"prefix":"mr","prefix_display":"MR.","first_name":"GARRETT","nickname":null,"middle_name":null,"last_name":"VENTRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":41,"name":"Treasury, Dept of"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in LLY
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 10, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Oct 20, 2026 · disclosed Nov 10, 2026
Traded 9 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Jul 1, 2026 · disclosed Aug 7, 2026
Committee overlap: Energy and CommerceGot $1K from the company’s PAC - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Jan 2, 2026 · disclosed Aug 7, 2026 · filed 217 days later
Committee overlap: Energy and CommerceGot $1K from the company’s PAC - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Dec 2, 2025 · disclosed Aug 7, 2026 · filed 248 days later
Committee overlap: Energy and CommerceGot $1K from the company’s PAC - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Sold (full) Eli Lilly and Company LLY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
- Jul 2, 2026$50K–$100K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Eli Lilly and Company LLY
$50K–$100K · Traded Jun 10, 2026 · disclosed Jul 2, 2026
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.